Mesirow Financial Investment Management Equity & Fixed Income Nuvasive Inc Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$97.3 Million
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$44.53 - $58.9 $6.8 Million - $9 Million	-152,810 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$47.64 - $71.26 $7.28 Million - $10.9 Million	152,810 New	152,810 $7.57 Million
Q3 2018 Oct 29, 2018	SELL	$52.03 - $71.41 $14.5 Million - $19.9 Million	-278,645 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$48.15 - $56.68 $1.97 Million - $2.32 Million	40,895 Added 17.2%	278,645 $14.5 Million
Q1 2018 May 09, 2018	BUY	$46.03 - $61.28 $10.9 Million - $14.6 Million	237,750 New	237,750 $12.4 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account